These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4826982)

  • 21. Heterologous resistance to Fasciola hepatica conferred upon rats by passive transfer of serum from different breeds of sheep.
    Boyce WM; Courtney CH; Thibideau M
    Vet Parasitol; 1986 Dec; 22(3-4):259-66. PubMed ID: 3564329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired immunity to Fasciola hepatica in the laboratory white mouse.
    Lang BZ
    Am J Trop Med Hyg; 1968 Jul; 17(4):561-7. PubMed ID: 5672785
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful passive transfer of resistance to Fasciola hepatica infection in rats by immune serum and transfer factor.
    Mitchell GB; Armour J; Ross JG; Halliday WG
    Res Vet Sci; 1981 Mar; 30(2):246-7. PubMed ID: 7255916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to reinfection with Fasciola hepatica in the rabbit.
    Kendall SB; Sinclair IJ
    Res Vet Sci; 1971 Jan; 12(1):74-9. PubMed ID: 5575471
    [No Abstract]   [Full Text] [Related]  

  • 25. Worm recovery, haemagglutinating antibodies and IgE-levels after immunisation against Fasciola hepatica in rats.
    Pfister K; Turner K; Wedrychowicz H
    Vet Parasitol; 1985 Jan; 17(2):139-50. PubMed ID: 3992868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naturally acquired immunity to Fasciola hepatica in the rat.
    Goose J; Macgregor M
    Br Vet J; 1973; 129(4):xlix-lii. PubMed ID: 4733763
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible role of excretory/secretory products in evasion of host defences by Fasciola hepatica.
    Goose J
    Nature; 1978 Sep; 275(5677):216-7. PubMed ID: 692694
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on heterologous resistance between Schistosoma mansoni and Fasciola hepatica in inbred rats.
    Ford MJ; Taylor MG; McHugh SM; Wilson RA; Hughes DL
    Parasitology; 1987 Feb; 94 ( Pt 1)():55-67. PubMed ID: 3103048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence on the effect of bithionol ("Actamer") on Fasciola hepatica.
    Dawes B
    Wiad Parazytol; 1968; 14(5):575-7. PubMed ID: 5712594
    [No Abstract]   [Full Text] [Related]  

  • 30. [Examination of new anti-fasciola agents. I. Efficacy and toxicity of rafoxanide in sheep, artificially infected with Fasciola hepatica and F. gigantica].
    Boray JC; Wolff K; Trepp HC
    Schweiz Arch Tierheilkd; 1973 Aug; 115(8):367-71. PubMed ID: 4732459
    [No Abstract]   [Full Text] [Related]  

  • 31. [Occurrence of Fasciola hepatica in deer (Capreolus capreolus) and red deer (Cervus elaphus) and its treatment using rafoxanide].
    Barth D; Schaich K
    Dtsch Tierarztl Wochenschr; 1973 Sep; 80(18):420-4 contd. PubMed ID: 4594866
    [No Abstract]   [Full Text] [Related]  

  • 32. Fasciola hepatica: some properties of a precipitate which forms when metacercariae are cultured in immune rat serum.
    Howell MJ; Sandeman RM
    Int J Parasitol; 1979 Feb; 9(1):41-5. PubMed ID: 447443
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen.
    Hillyer GV
    Am J Trop Med Hyg; 1985 Nov; 34(6):1127-31. PubMed ID: 3834796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the effect of various anthelmintics upon Fasciola hepatica in albino rats.
    Ray RJ
    Res Vet Sci; 1970 Jan; 11(1):1-6. PubMed ID: 5503920
    [No Abstract]   [Full Text] [Related]  

  • 35. Fasciola hepatica L. and fascioliasis: physiological, biochemical, pathogenic, immunologic, and diagnostic aspects.
    Locatelli A; Simonic T
    Folia Vet Lat; 1974 Jan; 4(1):43-70. PubMed ID: 4603539
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypersensitivity in rats infected with Fasciola hepatica: lack of correlation between serum reaginic antibody levels and rejection of flukes.
    Doy TG; Hughes DL; Harness E
    Res Vet Sci; 1981 May; 30(3):357-9. PubMed ID: 7255930
    [No Abstract]   [Full Text] [Related]  

  • 37. The demonstration of pre-hepatic immune response to Fasciola hepatica in the mouse.
    Harness E; Hughes DL; Doy TG
    Int J Parasitol; 1976 Feb; 6(1):15-7. PubMed ID: 1254388
    [No Abstract]   [Full Text] [Related]  

  • 38. The chemotherapeutic activity of selected fasciolicides against immature Fasciola hepatica in mice.
    Hayes TJ; Bailer J; Mitrovic M
    Experientia; 1973; 29(7):899-900. PubMed ID: 4724736
    [No Abstract]   [Full Text] [Related]  

  • 39. Conservative management of biliary obstruction due to Fasciola hepatica.
    Mannstadt M; Sing A; Leitritz L; Brenner-Maucher K; Bogner J
    Clin Infect Dis; 2000 Nov; 31(5):1301-3. PubMed ID: 11073771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Flow cytometry analysis of leukocytes response in rats immunized and infected with Fasciola hepatica].
    Jedlina-Panasiuk L
    Wiad Parazytol; 2004; 50(3):477-81. PubMed ID: 16865956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.